Search

Maryland man claims he went blind after taking Ozempic, shares warning for other users - New York Post

Maryland man claims he went blind after taking Ozempic, shares warning for other users - New York Post
A Maryland man has come forward with a shocking claim that a widely-used weight-loss medication, Ozempic, is responsible for his total vision loss, rendering him legally blind. Todd Engel, a 63-year-old resident of the state, was initially prescribed Ozempic in early 2023 as part of his treatment plan to manage his diabetes. The drug, which has gained popularity for its effectiveness in promoting weight loss and regulating blood sugar levels, has been a go-to for many individuals seeking to combat obesity and related health issues. However, Engel's alarming experience sheds light on potential side effects that have not been widely discussed in relation to the medication. Engel's journey with Ozempic began with optimism, as he hoped the drug would help him achieve better health outcomes. Initially, he reported positive changes in his blood sugar levels and weight management, which encouraged him to continue using it. However, his experience took a dramatic turn when he began to notice troubling changes in his vision. Engel describes the onset of symptoms as a gradual decline in his eyesight, eventually culminating in a complete loss of vision. His doctors were unable to provide a clear explanation for the sudden deterioration, leading Engel to suspect a connection to the medication he had been taking. The link between Ozempic and vision loss is a serious concern that has prompted Engel to take action. He has filed a lawsuit against the manufacturers of the drug, seeking accountability for the adverse effects he has suffered. Engel’s case is not an isolated incident; there have been reports from other users of Ozempic experiencing similar vision-related issues. This has raised questions about the drug's safety profile and the need for more comprehensive studies to investigate potential side effects that may not have been adequately disclosed to patients. Engel’s situation has sparked discussions about the importance of informed consent when it comes to prescription medications, particularly those that are as widely prescribed as Ozempic. As the story unfolds, it highlights the critical balance between the benefits of weight-loss medications and their potential risks. For many individuals, the allure of rapid weight loss and improved health can overshadow the need for caution and thorough medical guidance. Engel's experience serves as a poignant reminder that patients must be vigilant about understanding the possible side effects of any medication they are prescribed. It also underscores the importance of ongoing research and monitoring of medications that have quickly gained popularity, ensuring that patients have access to the most current and accurate information about the risks associated with their treatments. Engel’s fight for justice may not only affect his life but could also have broader implications for thousands of others who rely on medications like Ozempic for their health and wellbeing.